Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

4.940
-0.270-5.18%
Volume:183.70K
Turnover:896.81K
Market Cap:1.93B
PE:-8.98
High:5.080
Open:4.500
Low:4.500
Close:5.210
52wk High:77.000
52wk Low:4.500
Shares:391.00M
HK Float Shares:386.00M
Volume Ratio:0.15
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.550
ROE:-125.57%
ROA:-44.55%
PB:6.19
PE(LYR):-8.98
PS:-144.19

Loading ...

Movement Alert|PEGBIO CO-B Declines 8.64% in Regular Trading, Trading at HK$5.4

Market Focus
·
Jul 30

Movement Alert|PEGBIO CO-B Falls 8.36% in Regular Trading, Trading at 5.81 HKD

Market Focus
·
Jul 28

Movement Alert|PEGBIO CO-B Declines 8.12% in Regular Trading, Trading at 6.36 HKD

Market Focus
·
Jul 24

PegBio's Diabetes Drug Completes First Batch of Prescriptions

MT Newswires Live
·
Jul 22

PegBio’s Paidakang® Enters Clinical Use Nationwide, Unlocks HK$49.00 Million Second Royalty from Tenry Pharmaceutical

Bulletin Express
·
Jul 22

PEGBIO CO-B Announces First Commercial Prescriptions for Paidakang and Fulfillment of Second Milestone Payment

Stock News
·
Jul 22

Movement Alert|PegBio Rises 8.04% in Regular Trading, Three-Party Strategic Cooperation Accelerates Paidakang Commercialization Expectations

Market Focus
·
Jul 21

PEGBIO CO-B Surges Over 5% on Strategic Collaboration to Accelerate Commercialization of Pai Da Kang

Stock News
·
Jul 20

Alibaba Health Inks Strategic Tie-up with Tenry, Pegbio to Launch Glp-1ra Drug

Reuters
·
Jul 17

Alibaba Health Says it Signed Strategic Cooperation with Tenry Pharmaceutical and Pegbio on Glp-1ra Drug

THOMSON REUTERS
·
Jul 17

PegBio, Tengrui Pharma, and Ali Health Forge Strategic Alliance to Accelerate Commercialization and Market Expansion of Patacon

Stock News
·
Jul 17

Movement Alert|PegBio Intraday Decline 8.04%, Rani Therapeutics Catalyst Fading Amid Broad Biotech Sector Selloff

Market Focus
·
Jul 17

Movement Alert|PegBio Pharma-B Rises 8.78% in Regular Trading, Technical Rebound After Prior Session Pullback With Rani Collaboration Catalyst Intact

Market Focus
·
Jul 15

Movement Alert|PegBio Intraday Decline 8.11%, Profit-Taking Emerges After Rani Therapeutics Partnership Rally

Market Focus
·
Jul 14

Movement Alert|PegBio Rises 8.42% in Regular Trading, Rani Therapeutics Oral Delivery Partnership Continues to Fuel Market Enthusiasm

Market Focus
·
Jul 13

Movement Alert|PegBio Rises 38.16% in Regular Trading, Partners with Rani Therapeutics to Advance Oral Delivery of Metabolic Assets

Market Focus
·
Jul 10

PEGBIO Shares Surge Over 21% on Oral Delivery Collaboration with Rani Therapeutics

Stock News
·
Jul 10

PegBio Partners with Rani: Oral Delivery Platform Opens Global Revaluation Path for Next-Generation Metabolic Assets

Stock News
·
Jul 10

Pegbio Co - Enters Mou with Nasdaq-listed Rani Therapeutics

THOMSON REUTERS
·
Jul 10

Pegbio Co - Collaboration to Advance Oral Delivery of Multiple Metabolic Assets

THOMSON REUTERS
·
Jul 10